🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and efficacy of OTX-DP as a sustained release drug (...
Status
Completed
Location
Chicago Cornea Consultants, Ltd.
Start Date
2012-10
Trial ID
NCT01666210
Treatments Being Tested
The purpose of this study is to confirm the clinical efficacy and the safet...
Status
Completed
Location
Site #102
Start Date
2016-08-02
Trial ID
NCT03004469
Treatments Being Tested
The primary objective of this study is to determine the safety and efficacy...
Status
Completed
Location
Clinical Research Associates
Start Date
2013-10
Trial ID
NCT01913158
Treatments Being Tested
A multicenter randomized controlled trial on prevention and treatment of oc...
Status
Unknown
Location
Yingli Li
Start Date
2018-06
Trial ID
NCT03515187
A Phase 2 Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Ascen...
Status
Completed
Location
PPD 137
Start Date
2015-06-12
Trial ID
NCT02462187
Treatments Being Tested
The purpose of this study is to determine whether DRM02 is safe and effecti...
Status
Completed
Location
Clinique Médicale Dr Isabelle Delorme
Start Date
2013-10
Trial ID
NCT01993433
The purpose of this study is to assess the efficacy and safety of twice dai...
Status
Completed
Location
Cahaba Dermatology
Start Date
2018-12-20
Trial ID
NCT03745638
Treatments Being Tested
The TRANQUILITY Trial: Multi-Center Randomized, Double-Masked, Parallel Des...
Status
Completed
Location
University Clinical Health
Start Date
2020-11-21
Trial ID
NCT04674358
Treatments Being Tested
The purpose of this study is to determine if 0.5% Ivermectin Cream is a saf...
Status
Completed
Location
Arkansas Pediatric Clinic
Start Date
2010-03
Trial ID
NCT01068158
Treatments Being Tested
The purpose of this research study is to test if an experimental drug calle...
Status
Withdrawn
Location
J. Edward Puzas
Start Date
2008-12
Trial ID
NCT00787358